Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Arterial Cannula Market Size & Growth Forecast 2026–2035, By Segments (Application, End Use, Size), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 11716| Published Date: Mar-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Arterial Cannula Market size was over USD 22.93 Million in 2025 and is likely to grow at a 7.6% CAGR between 2026 and 2035, surpassing USD 47.7 Million by 2035. The industry revenue for 2026 is estimated at USD 24.46 million.

Base Year Value (2025)
USD 22.93 Million
CAGR (2026-2035)
7.6%
Forecast Year Value (2035)
USD 47.7 Million
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Arterial Cannula Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 42.88% share in 2025, supported by high cardiovascular procedure volumes, advanced hospital infrastructure, and consistent arterial cannula use across major cardiac centers.
  • Asia Pacific is expected to grow at an 8.59% CAGR as expanding hospital capabilities and increasing cardiac procedure volumes strengthen demand across developing healthcare systems.

Segment Momentum

  • ECMO accounted for 44.52% of the market in 2025 due to its reliance on arterial cannulas for prolonged circulatory and respiratory support in high-acuity hospital settings.
  • Ambulatory Surgical Centers are the fastest-growing end-use segment as healthcare providers increasingly shift appropriate procedures to efficient outpatient facilities focused on streamlined surgical workflows and cost control.

Market Expansion Drivers

  • Rising cardiovascular disease prevalence increasing demand for CABG and ECMO procedures.
  • Growing adoption of minimally invasive surgeries driving demand for advanced biocompatible cannulas.
  • Expanding elderly population and diabetes incidence strengthening long-term cardiovascular intervention volumes.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Leading companies in the arterial cannula market include Medtronic plc (Ireland), Getinge AB (Sweden), LivaNova PLC (United Kingdom), Edwards Lifesciences Corporation (United States), Becton, Dickinson and Company (United States), Fresenius Medical Care AG & Co. KGaA (Germany), Nipro Corporation (Japan), Andocor NV (Belgium), Kangxin Medical Technology Co., Ltd. (China), Surgical Holdings Limited (United Kingdom).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising cardiovascular disease prevalence increasing demand for CABG and ECMO procedures

As cardiovascular disease becomes more prevalent, hospitals are handling a larger volume of patients requiring coronary artery bypass grafting and extracorporeal membrane oxygenation, both of which depend on reliable arterial access during complex circulatory support. This is driving demand for the arterial cannula market because procedure growth translates directly into higher consumption of arterial cannulas in cardiac surgery units, perfusion departments, and intensive care settings. The effect is particularly strong in acute and high-risk cases, where clinicians prioritize cannulas that can deliver stable flow, minimize vascular trauma, and support rapid procedural setup, shaping purchasing decisions toward specialized product configurations rather than basic commodity supply.

Growing adoption of minimally invasive surgeries driving demand for advanced biocompatible cannulas

The shift toward minimally invasive cardiac and circulatory procedures is influencing market adoption by changing what surgeons and perfusion teams require from arterial access devices. In the arterial cannula market, this favors advanced biocompatible cannulas designed for smaller access points, improved maneuverability, and reduced risk of vessel injury or inflammatory response during technically demanding procedures. Procurement increasingly reflects compatibility with refined surgical techniques, as providers look for devices that support shorter recovery pathways and lower complication burdens, strengthening market development for premium cannula designs over conventional alternatives.

Expanding elderly population and diabetes incidence strengthening long-term cardiovascular intervention volumes

An expanding elderly population combined with rising diabetes incidence is contributing to market size growth by increasing the number of patients living with progressive vascular and cardiac conditions that eventually require surgical or mechanical circulatory intervention. In the arterial cannula market, this creates sustained procedure demand rather than isolated episodic usage, since older and metabolically compromised patients are more likely to need bypass-related support, reinterventions, or critical care management involving arterial cannulation. Hospitals and cardiac centers respond by maintaining broader cannula inventories and placing greater emphasis on product reliability across varied patient anatomies and risk profiles, reinforcing market demand through routine clinical utilization.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising cardiovascular disease prevalence increasing demand for CABG and ECMO procedures 2.10% High North America, Europe High Near Term
Growing adoption of minimally invasive surgeries driving demand for advanced biocompatible cannulas 1.80% High North America, Asia Pacific High Mid Term
Expanding elderly population and diabetes incidence strengthening long-term cardiovascular intervention volumes 1.50% Moderate Asia Pacific, Europe Medium Long Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
42.88% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 42.88% share of the arterial cannula market in 2025, bolstered by the region’s high volume of cardiovascular and critical care procedures, where arterial cannulas are routinely used for extracorporeal circulation and related hospital interventions. Its leadership is sustained by established surgical infrastructure, broad access to advanced hospital care, and consistent product utilization across major cardiac centers, which keeps demand anchored in everyday clinical practice rather than episodic procurement.

Asia Pacific is projected to expand at an 8.59% CAGR over the forecast period, with growth in the arterial cannula market being impelled by rising procedure volumes and the ongoing expansion of hospital capabilities across developing healthcare systems. Adoption is accelerating as more providers build capacity for cardiac surgery and intensive care, creating practical demand for arterial cannulas in a wider range of treatment settings and increasing product penetration across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Precision Surgical Devices

Germany focuses on arterial cannulas that support high standards in cardiovascular surgery and perfusion procedures. Hospitals in Germany emphasize product quality, reliable clinical performance, and compatibility with sophisticated operating room technologies.

France 🇫🇷

Surgical Care Standardization

France prioritizes arterial cannulas that align with standardized cardiovascular treatment protocols and hospital quality requirements. Clinical teams in France emphasize dependable product performance and ease of use during complex cardiac procedures.

Italy 🇮🇹

Cardiovascular Treatment Efficiency

Italy supports arterial cannula adoption across hospitals performing cardiovascular and critical care procedures. Healthcare providers in Italy focus on products that improve procedural reliability while meeting established clinical practice requirements.

Japan 🇯🇵

Minimally Invasive Compatibility

Japan promotes arterial cannulas designed for precise cardiovascular interventions and evolving surgical techniques. Medical institutions in Japan value dependable device performance that supports procedural accuracy and improved patient management during complex surgeries.

South Korea 🇰🇷

Advanced Perfusion Solutions

South Korea expands the use of arterial cannulas through continued investment in specialized cardiac care facilities. Healthcare providers in South Korea seek devices that integrate efficiently with modern perfusion equipment while supporting consistent clinical outcomes.

United States 🇺🇸

Cardiac Procedure Support

The U.S. maintains consistent demand for arterial cannulas driven by cardiac surgery, extracorporeal circulation, and critical care applications. Healthcare providers in the U.S. prioritize products that enhance procedural efficiency, patient safety, and compatibility with advanced perfusion systems.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Arterial Cannula Market Share (%), Application, 2025

Extracorporeal Membrane Oxygenation (ECMO)
Cardiopulmonary Bypass Surgery
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Application Segment Analysis: Extracorporeal Membrane Oxygenation (ECMO) (Largest Segment) vs Cardiopulmonary Bypass Surgery (Fastest-Growing Segment)

Within the arterial cannula market, Extracorporeal Membrane Oxygenation (ECMO) held a 44.52% share in 2025, making it the leading application segment. This leadership is maintained through the intensive clinical requirements of ECMO procedures, where arterial cannulas are essential for prolonged circulatory and respiratory support in critically ill patients. The segment’s share remains strong because ECMO use typically involves high-acuity hospital settings, specialized perfusion teams, and procedure-driven demand for reliable cannulation systems, all of which reinforce steady consumption in the arterial cannula market.

Cardiopulmonary Bypass Surgery is emerging as the fastest-growing application in the arterial cannula market as procedural demand continues to benefit from the ongoing need for controlled circulation during cardiac operations. Its growth momentum is aided by the direct procedural dependence on arterial cannulation in bypass settings, where efficiency, surgical workflow, and compatibility with operating room protocols matter more than in less procedure-intensive applications. Compared with alternatives, Cardiopulmonary Bypass Surgery is gaining faster traction because its demand is closely tied to expanding surgical activity rather than only long-duration critical care use.

End Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Hospitals accounted for a 58.28% share of the arterial cannula market in 2025, establishing them as the dominant end-use segment. Their leadership reflects the concentration of complex cardiovascular and critical care procedures in hospital environments, where ECMO and cardiopulmonary bypass interventions are routinely performed. Hospitals maintain this share because they have the infrastructure, specialist teams, and perioperative support required for high-risk cannulation procedures, making them the primary setting for sustained arterial cannula market demand.

Ambulatory Surgical Centers represent the fastest-growing end-use segment in the arterial cannula market, influenced by the increasing shift of suitable surgical procedures toward more efficient outpatient-focused care settings. Their momentum comes from operational models that prioritize streamlined case turnover, cost control, and procedure standardization, which can support growing use of arterial cannulas in selected interventions. Relative to traditional care settings, Ambulatory Surgical Centers are expanding faster as healthcare providers continue to move appropriate surgical volumes into facilities designed for procedural efficiency.

Segment Sub-Segment Largest Segment Fastest Growing
Application Cardiopulmonary Bypass Surgery, Extracorporeal Membrane Oxygenation (ECMO), Others Extracorporeal Membrane Oxygenation (ECMO) Cardiopulmonary Bypass Surgery
End Use Hospitals, Ambulatory Surgical Centers, Others Hospitals Ambulatory Surgical Centers
Size 14-16 Fr, 17-19 Fr, 20-22 Fr, 23-25 Fr, 26-28 Fr, 29- 31 Fr, 32-34 Fr, 35-36 Fr 20-22 Fr 35-36 Fr
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the arterial cannula market:

1. Medtronic plc (Ireland)

2. Getinge AB (Sweden)

3. LivaNova PLC (United Kingdom)

4. Edwards Lifesciences Corporation (United States)

5. Becton Dickinson and Company (United States)

6. Fresenius Medical Care AG & Co. KGaA (Germany)

7. Nipro Corporation (Japan)

8. Andocor NV (Belgium)

9. Kangxin Medical Technology Co. Ltd. (China)

10. Surgical Holdings Limited (United Kingdom)

The arterial cannula market is witnessing ongoing innovation focused on improving procedural safety, flow performance, and patient outcomes in cardiovascular procedures. Manufacturers are enhancing product designs and expanding manufacturing capabilities to meet rising demand for advanced minimally invasive surgical solutions.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Shockwave Medical Sep-24 Shockwave Medical expanded its peripheral intravascular lithotripsy (IVL) portfolio with the U.S. launch of the Shockwave E8 catheter. Designed for treating calcified arterial lesions, this innovation provides enhanced reach and efficiency in vascular procedures. By addressing complex calcified disease, the device strengthens the company’s competitive position in the arterial intervention space and supports clinical outcomes in patients with peripheral artery disease.
Arrow International Apr-24 The FDA initiated a Class I recall of Arrow International’s QuickFlash Radial Artery Catheterization Kits due to device malfunctions involving increased resistance. This significant quality-related action impacted over 330,000 units, highlighting critical supply chain and manufacturing safety standards. The recall underscores the potential for procedural risks in arterial access and necessitates rigorous quality control measures for manufacturers within the arterial cannula market.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Arterial Cannula Market — Custom Segments

Segment Sub-Segment
No segment data available.

Arterial Cannula Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the current revenue of the arterial cannula market?

The market revenue for arterial cannula is anticipated at USD 24.46 million in 2026.

How much is the arterial cannula industry expected to grow by 2035?

Arterial Cannula Market size is projected to expand significantly moving from USD 22.93 million in 2025 to USD 47.7 million by 2035 with a CAGR of 7.6% during the 2026-2035 forecast period.

How are rising CABG and ECMO procedure volumes impacting demand in the arterial cannula market?

Rising volumes of CABG and ECMO procedures are increasing arterial cannula consumption in cardiac surgery and intensive care settings, as clinicians prioritize stable flow performance, rapid setup, and reduced vascular trauma in high-risk cardiovascular interventions.

How are minimally invasive procedures and demographic shifts influencing arterial cannula adoption trends?

Minimally invasive cardiac procedures and rising elderly and diabetic populations are driving demand for advanced biocompatible arterial cannulas designed for smaller access points, improved maneuverability, and reduced complication risks in long-duration vascular support cases.

Why is Extracorporeal Membrane Oxygenation (ECMO) the largest application in the arterial cannula market?

ECMO accounted for 44.52% of the market in 2025 due to its reliance on arterial cannulas for prolonged circulatory and respiratory support in high-acuity hospital settings.

Which end-use segment is expanding fastest in the arterial cannula market?

Ambulatory Surgical Centers are the fastest-growing end-use segment as healthcare providers increasingly shift appropriate procedures to efficient outpatient facilities focused on streamlined surgical workflows and cost control.

Why does North America dominate the arterial cannula market?

North America held a 42.88% share in 2025, supported by high cardiovascular procedure volumes, advanced hospital infrastructure, and consistent arterial cannula use across major cardiac centers.

Why is Asia Pacific experiencing rapid growth in the arterial cannula market?

Asia Pacific is expected to grow at an 8.59% CAGR as expanding hospital capabilities and increasing cardiac procedure volumes strengthen demand across developing healthcare systems.

Which companies are driving growth in the arterial cannula landscape?

Leading companies in the arterial cannula market include Medtronic plc (Ireland), Getinge AB (Sweden), LivaNova PLC (United Kingdom), Edwards Lifesciences Corporation (United States), Becton, Dickinson and Company (United States), Fresenius Medical Care AG & Co. KGaA (Germany), Nipro Corporation (Japan), Andocor NV (Belgium), Kangxin Medical Technology Co., Ltd. (China), Surgical Holdings Limited (United Kingdom).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →